🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to officially start commercial TriClip at Vanderbilt today, just as we head to #NYValves2024!! Great result with trace residual TR Privileged to work with such a great structural and imaging team! Barker Keniel, M.D. Amy Woodard

Vanderbilt Internal Medicine resident, Lamiya Rodriguez, did an amazing job presenting the outcomes of T-TEER in ESRD patients at #NYValves2024 Superb presentation! VUMC Department of Medicine Cardiovascular Research Foundation Vanderbilt Internal Medicine Residency

Had an amazing time at #NYValves2024 in NYC!! Lots of education, learning, connections and networking! This is the best meeting for Structural Heart Disease enthusiasts. Looking forward to #NYValves2025

It was an honor to present the latest update on the Early Feasibility Study of Innovalve TMVR at NY Valves, on behalf of all the investigators, patients and research teams. Looking forward to the next steps with this innovative technology

The best feeling one can get -- Receiving the "MVP" award and chain from outgoing IC and SHD fellows. Honored to be a part of their path! Keniel, M.D. Vanderbilt Cardiology Fellowship

17d to #CVI2024! attendance already +24% since last yr. See u there! CV Innovations Minneapolis Heart Institute Foundation Marcus R. Burns Konstantinos Voudris Nadira Hamid Adnan Chhatriwalla Philippe Genereux Rahul Sharma Rahul Sharma, MD Mark J Ricciardi MD Allina Health Sachin Goel Marvin H. Eng, MD Jamie McCabe cvi2024.eventbrite.com

#TTVR is revolutionary treatment for TR. Speak up, support & submit Public comments for National Coverage Analysis (NCA) - Transcatheter Tricuspid Valve Replacement (TTVR) (CAG-00467N) Ends July 20th ⁦American College of Cardiology⁩ ⁦SCAI Now⁩ #TTVR cms.gov/medicare-cover…

Very important for all of us to advocate for TTVR coverage..

Happy Cath lab, Anesthesia, Research and valve teams after 2 more successful cases of TTVR with Trisol Tricuspid Valve in the EFS! Participating and enrolling in EFS takes a lot of time and effort, but our team does it with ease. I feel so proud to work alongside all of them!

How would you treat this complex mitral case? - Short posterior leaflet - Double flail - A3/P3 - Severe MR and pulm edema Will discuss this case tomorrow at CVI 2024 during the session on “Ultimate Mitral Cases” Paul Nadira Hamid Sachin Goel Abdallah El Sabbagh

Had an amazing time at CV Innovations #CVI2024. This is the best case-based structural conference led by Paul. Learned so many new techniques!! Our star IC and SHD fellows also presented complex cases in the structural case competitions as semifinalists

Structural Heart Disease Fellowship – 2025 Vanderbilt University Medical Center has one opening for the Structural Heart Disease Fellowship. This position offers advanced training in one of the nation’s top Valve Centers. 🔹 Apply Here: medicine.vumc.org/divisions/card… The application

Proud to announce that the Vanderbilt Structural and Valve Center has successfully performed the world’s first Laplace TTVR with in-situ RV lead for symptomatic severe tricuspid regurgitation as part of the EFS. 🌍 Outstanding result with no residual TR! This marks a significant

Hot off the press! Our latest study in @Circulation reports 1-year outcomes for transseptal Mitral Valve-in-Valve, featuring the largest dataset to date! With the recent approval for intermediate risk, discover the impressive results of transseptal mitral VIV in patients with

Early insight into the #TriClip commercial experience around the US. Much thanks to Dr. Gilbert Tang Bruce Rutkin MD / [email protected] Kashish Goel Brandon Jones, MD and hospital PR folks who helped me navigate thunderstorms and dropped calls. tctmd.com/news/initial-u…

Had an amazing time teaching the MitraClip 101 course in Austin last week! Grateful for the opportunity to share and grow with >50 participants from all over the country. Thanks to all who joined and are now ready to start Clipping ! #MitraClip101 Abbott

After ranking among the top 10 enrollers in the TRISCEND II trial, we’re thrilled to kick off the commercial TTVR program with Evoque at Vanderbilt. Huge thanks to our incredible team and VUMC for making it possible! 🚀 #TTVR #Innovation #VUMC Barker Vanderbilt Structural Heart & Valve Center